News and media
News and media
Discover the latest news about motor neurone disease (MND) advocacy and research or visit our one-stop-shop for media,
Media hub.
Got a story to share?
Tell us about how MND has impacted your life.
News List
| 22/06/2017
MND Australia has a Communications and Information Manager position available for an experienced, highly motivated individual with a communications or marketing degree and strong oral and written communication skills.
| 14/06/2017
The latest issue of the International Research Update features snippets on recent research into the involvement of motor neurones with other types of cells and environmental factors in MND. Also read about researchers who have developed new imaging and biochemical tests for diagnosis and disease stage assessment, and a new tool to help in working out a way to stop the spread of MND through the body.
| 8/06/2017
Senior Queensland Australian of the Year and now Queensland Great, Professor Perry Bartlett is delighted to share his award with the Queensland Brain Institute (QBI).
| 5/06/2017
The MND Research Institute of Australia's Advance newsletter has a new look and is now easier to read. Catch up on recent MND research advances that have been supported by our generous donors, bequestors and State MND Associations.
| 16/05/2017
What does Budget 2017 – 2018 mean to people living with MND in Australia? MND Australia has prepared this response to the national Budget, which was handed down by the Treasurer on 9 May 2017.
| 27/04/2017
In this issue we provide an update of recent influencing efforts related to the National Disability Insurance Scheme (NDIS) and Aged Care.
| 6/04/2017
MND Australia has a part-time Research Manager position available for a highly motivated individual with a biomedical or related science degree, and strong oral and written communication skills.
| 23/03/2017
MNDRIA's Beryl Bayley Postdoctoral Fellow, Dr Michelle Farrar from the University of NSW, is spearheading Australian research into an emerging treatment called nusinersen that has been shown in clinical trials to improve motor development in babies and children with spinal muscular atrophy (SMA), a disease of the motor neurones that most often affects infants. Several Australian infants have participated in these pivotal clinical trials.
| 22/03/2017
Today a joint position paper will be launched by the Neurological Alliance Australia at Parliament House, Canberra to call for equitable and effective support within the NDIS for people with progressive neurodegenerative diseases.